| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |